State of New Jersey Common Pension Fund D’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-34,455
| Closed | -$5.93M | – | 1825 |
|
|
2021
Q3 | $5.93M | Buy |
34,455
+375
| +1% | +$49.1K | 0.02% | 666 |
|
|
2021
Q2 | $4.28M | Buy |
34,080
+938
| +3% | +$118K | 0.01% | 817 |
|
|
2021
Q1 | $4.49M | Buy |
33,142
+2,125
| +7% | +$274K | 0.02% | 795 |
|
|
2020
Q4 | $3.97M | Sell |
31,017
-2,513
| -7% | -$295K | 0.01% | 835 |
|
|
2020
Q3 | $3.77M | Sell |
33,530
-1,068
| -3% | -$106K | 0.02% | 775 |
|
|
2020
Q2 | $3.3M | Sell |
34,598
-14,628
| -30% | -$1.41M | 0.01% | 832 |
|
|
2020
Q1 | $4.42M | Hold |
49,226
| – | – | 0.02% | 622 |
|
|
2019
Q4 | $2.61M | Sell |
49,226
-7,174
| -13% | -$327K | 0.01% | 1130 |
|
|
2019
Q3 | $2.23M | Sell |
56,400
-31,600
| -36% | -$1.37M | 0.01% | 1303 |
|
|
2019
Q2 | $3.62M | Hold |
88,000
| – | – | 0.01% | 638 |
|
|
2019
Q1 | $4.1M | Buy |
88,000
+35,000
| +66% | +$1.54M | 0.02% | 612 |
|
|
2018
Q4 | $2.31M | Hold |
53,000
| – | – | 0.01% | 686 |
|
|
2018
Q3 | $3.03M | Hold |
53,000
| – | – | 0.01% | 678 |
|
|
2018
Q2 | $2.57M | Hold |
53,000
| – | – | 0.01% | 735 |
|
|
2018
Q1 | $2.07M | Hold |
53,000
| – | – | 0.01% | 763 |
|
|
2017
Q4 | $2.25M | Hold |
53,000
| – | – | 0.01% | 726 |
|
|
2017
Q3 | $1.98M | Buy |
53,000
+35,000
| +194% | +$1.21M | 0.01% | 744 |
|
|
2017
Q2 | $547K | Hold |
18,000
| – | – | ﹤0.01% | 881 |
|
|
2017
Q1 | $476K | Hold |
18,000
| – | – | ﹤0.01% | 887 |
|
|
2016
Q4 | $459K | Hold |
18,000
| – | – | ﹤0.01% | 880 |
|
|
2016
Q3 | $651K | Hold |
18,000
| – | – | ﹤0.01% | 855 |
|
|
2016
Q2 | $612K | Hold |
18,000
| – | – | ﹤0.01% | 854 |
|
|
2016
Q1 | $475K | Hold |
18,000
| – | – | ﹤0.01% | 888 |
|
|
2015
Q4 | $878K | Hold |
18,000
| – | – | ﹤0.01% | 859 |
|
|
2015
Q3 | $448K | Hold |
18,000
| – | – | ﹤0.01% | 903 |
|
|
2015
Q2 | $570K | Hold |
18,000
| – | – | ﹤0.01% | 886 |
|
|
2015
Q1 | $685K | Hold |
18,000
| – | – | ﹤0.01% | 876 |
|
|
2014
Q4 | $701K | Hold |
18,000
| – | – | ﹤0.01% | 908 |
|
|
2014
Q3 | $544K | Hold |
18,000
| – | – | ﹤0.01% | 886 |
|
|
2014
Q2 | $611K | Buy |
+18,000
| New | +$602K | ﹤0.01% | 876 |
|
State of New Jersey Common Pension Fund D's XLRN Position: Q4 2021 in Review
State of New Jersey Common Pension Fund D sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 34,455 shares — an estimated $5.93M sold.
State of New Jersey Common Pension Fund D first reported a position in XLRN in Q2 2014 and held it in 30 quarters. The position peaked at $5.93M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- State of New Jersey Common Pension Fund D reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- State of New Jersey Common Pension Fund D sold 34,455 Acceleron Pharma shares in Q4 2021, an estimated $5.93M.
- State of New Jersey Common Pension Fund D first reported a position in Acceleron Pharma in Q2 2014 and held it in 30 quarters.
- State of New Jersey Common Pension Fund D's Acceleron Pharma position peaked at $5.93M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on State of New Jersey Common Pension Fund D's 13F filing for Q4 2021, filed 31 Jan 2022.